2018 Award Recipients: RFA for translational clinical protocol development
Margaret von Mehren, MD and Lori Rink, PhD, for their proposal, “Evaluation of Imatinib with ARQ092 alone or in combination with a PD-1 inhibitor in Advanced Gastrointestinal Stromal Tumors.” The award is effective April 15, 2018, in the amount of $100,000.
Joshua Meyer, MD and Edna Cukierman, PhD, for their proposal, “Utilizing pulsed Low-dose-rate radiation to prevent radiation-induced stromal activation; a neoadjuvant pancreatic adenocarcinoma phase I trial.” The award is effective April 15, 2018, in the amount of $99,942.
Margie Clapper, PhD and Michael Hall, MD, for their proposal, “Prevention of Colorectal Adenomas in Patients with Lynch Syndrome using Atorvastatin and Aspirin: An Exploratory Biomarker Trial.” The award is effective April 15, 2018, in the amount of $100,000.
Yanis Boumber, MD, PhD, and Suraj Peri, PhD, for their proposal, “Prospective clinical study of SCLC patients with NSD1, NSD2 mutations receiving platinum doublet chemotherapy.” The award is effective April 15, 2018, in the amount of $82,182.
2016 Award Recipients: RFA for assay development
Project: Use of urinary cell-free DNA to monitor somatic mutation clearance as a measure tumor response after neoadjuvant chemotherapy
Project: Detection of ESR1-CCDC170 fusion transcripts in breast tumores in situ
Project: Assay development to explore ERCC3 as a biomarker of disease free survival (DFS) and overall survival (OS) in renal cell carcinoma
Nasheed Hossain, Jianming Pei
Project: Utilizing NanoString Technology for the evaluation of Minimal Residual Disease in AML patients following Induction Chemotherapy
Jianming Pei, Tahseen Al-Saleem
Project: Leukemia Fusion Gene Expression Assay, a LDT for Clinical Leukemia Testing
Jianming Pei, Joseph Testa
Project: Identifying Biomarkers to Assess Asbestos Exposure Risk Using Plasma Samples
Jianming Pei, Wang, Tahseen Al-Saleem
Project: Identifying Biomarkers to Profile Minimal Residual Disease Signature in Multiple Myeloma Using Plasma Cell Enrichment and NanoString Immune Profiling Panel
Project: Development of chemosensitivity biomarker for potentially resectable pancreatic cancer
Project: Validation of a multi-parametric flow cytometry (MFC) model for evaluation of minimal residual disease (MRD) in Multiple Myeloma (MM) patients
Project: Assay development to rapidly establish genotype-phenotype correlations for gene variants associated with mitotic dysfunction, in hereditary cancers
2015 Award Recipients: RFA for rare tumor subtypes & exceptional responders
Paul Cairns, Neil Johnson, Suraj Peri, Michael J. Slifker, Essel Dulaimi Al-Saleem
Project: Delineation of a Novel Molecular Subtype of High Grade Serous Ovarian Cancer with Early Age of Onset by Multiple Genomic Views.
Joseph Testa, Mitchell Cheung, Jill Ohar
Project: NanoString Expression Profiling of Primary Pleural Malignant Mesothelioma of the Epithelioid Subtype to Discover and Expression Signature of Exceptional Responders
Namrata Vijayvergia, Igor Astsaturov, Suraj Peri, Paul Engstrom, Karen Gustafson, Karthik Devarajan
Project: Transcript profiling of neuroendocrine carcinoma to identify new targets and mechanism of progression
Jonathan Chernoff, James Duncan, Eric Ross
Project: Probing the kinome of K-Ras variants to uncover unique therapeutic vulnerabilities
Alfonso Bellacosa, Erica Golemis, Michael Hall, Maurizio Ponz de Leon
Project: Hereditary colorectal cancer gene discovery via exome sequencing of high-risk families
Lori Rink, Margaret von Mehren, James Duncan
Project: Identification of kinome signatures in genetically defined subgroups of Gastrointestinal Stromal Tumor
Marijo Bilusic, Elizabeth Plimack, Jianming Pei, Michael J. Slifker
Project: Molecular Profiling of Outlier Responses at FCCC
2014 Award Recipients
Project: Targeting glutathione biosynthesis in triple-negative breast cancer
Denise Connolly, Alana O'Reilly
Project: CDON: A novel marker of cancer stem cells in carcinomas of the pancreas and ovary
Vladimir Kolenko, Igor Astsaturov, Robert Uzzo
Project: LDL cholesterol and TKI resistance in renal cancer
Camille Ragin, Erica Golemis, Ranee Mehra, Jeffrey Liu
Project: Variation in genes regulating DNA repair and tobacco metabolism as factors regulating prognosis in head and neck cancer, for African-American and European-American populations,"
M. Raza Zaidi, Anthony Olszanski, Jeffrey Farma
Project: Novel biomarkers of melanoma prognosis and response to anti-CTLA4 therapy
James Duncan, Angela Jain
Project: Development of kinome activation signature to predict platinum resistance in high Grade serous ovarian carcinoma
Alfonso Bellacosa, Tim Yen, Igor Astsaturov, Andy Andrews
Project: 5-carboxylcytosine as a clinical biomarker of cancer cell response to temozolomide and TDG inhibitors